Nkarta, Inc. Common Stock

NKTXNASDAQ • USD
ThemeHealthcare - Oncology›Cell & Gene Therapy for Cancer
2.51 USD
↘ 0.26 (9.39%)AT CLOSE (11:59 AM EDT)
2.51
↘ 0.01 (0.20%)
POST MARKET (AS OF 07:49 PM EDT)
Post Market
AS OF 07:49 PM EDT
2.51
↘ 0.01 (0.20%)
🔴Market: CLOSED
Open?$2.76
High?$2.77
Low?$2.49
Prev. Close?$2.77
Volume?564.0K
Avg. Volume?690.7K
VWAP?$2.57
Rel. Volume?0.82x
Bid / Ask
Bid?$2.18 × 100
Ask?$2.88 × 100
Spread?$0.70
Midpoint?$2.53
Valuation & Ratios
Market Cap?179.6M
Shares Out?71.5M
Float?43.7M
Float %?61.6%
P/E Ratio?N/A
P/B Ratio?0.63
EPS?-$1.40
Dividend?0.00%
Ex-Dividend?N/A

Shares of Nkarta, Inc. Common Stock (NKTX) are trading at $2.51. The stock presents a bearish profile across the board: technical indicators signal "Strong Sell" and our fundamental models agree with a "Sell" rating. Notable factors include a concerning Altman Z-Score in the distress zone, a weak Piotroski F-Score of 0/9, negative Return on Equity and a bullish Golden Cross on the moving averages. The stock looks compelling on valuation, with multiples below sector averages across P/E, P/B, and EV/EBITDA.

Technical & fundamental data as of Jun 5, 2026.

News
Profile
Nkarta Inc is a clinical-stage biopharmaceutical company pioneering the development of allogeneic, off-the-shelf engineered natural killer (NK) cell therapies. The company is engaged in leveraging the natural potent power of NK cells to identify and kill abnormal cells and recruit adaptive immune effectors to generate responses that are specific and durable. The company is combining its NK-cell expansion platform technology with proprietary cell engineering technologies to generate an abundant supply of NK cells, engineer enhanced NK cell recognition of therapeutic targets, and improve persistence for sustained activity in the body for the treatment of cancer.
Themes
Healthcare - Oncology›Cell & Gene Therapy for CancerBiotech - Drug Development›Clinical-Stage Platforms
Employees
108
Market Cap
179.6M
Industry
PHARMACEUTICAL PREPARATIONS
Website
www.nkartatx.com
Listed
2020-07-10
Address
1150 VETERANS BOULEVARD
SOUTH SAN FRANCISCO, CA 94080
Phone: (925) 407-1049
Technical OutlookStrong Sell
Strong SellNeutralStrong Buy
Long-Term (Tide)?▼ Bearish(-1/3)
Medium-Term (Wave)?▼ Bearish(-3/3)
Short-Term (Ripple)?▼ Bearish(-3/3)
MA Alignment?Mixed
Full Technical Analysis →
Fundamental OutlookSell
Strong SellNeutralStrong Buy
F-Score?
3
Z-Score?
0
Momentum?
50
Short Sent.?
40
Piotroski F-Score?0/9Weak
Altman Z-Score?-1.62Distress
Confidence?51%Low
Full Fundamental Analysis →
Short InterestHigh
Short % of Float?11.80%High
Short Interest?5.2M
Days to Cover?5.9
Free Float43.7M
Avg Daily Volume873.9K
Settlement Date2026-05-15
Financial Health
Current Ratio?12.96Strong
Quick Ratio?12.96Strong
Cash Ratio?1.50Strong
Debt/Equity?0.00Low
ValuationATTRACTIVELY VALUEDvs 1 peers + S&P 500
Score
100/100
P/E?
N/A▾
P/B?
Peers
100
S&P
97
0.63CHEAP▾
P/S?
N/A▾
P/FCF?
N/A▾
EV/EBITDA?
S&P
97
-1.4CHEAP▾
EV/Sales?
N/A▾
Returns & Efficiency
ROE?
S&P
5
-35.2%WEAK▾
ROA?
S&P
3
-27.0%WEAK▾
Cash Flow & Enterprise
FCF?$-88389000
Enterprise Value?$152.2M
Fundamentals ratios updated end of day
MarketsMoversWatchlist